ConductScience.org, home

Paper4854

Inhibition of prostaglandin biosynthesis by sulphasalazine and its metabolites.

Collier HO and 3 others. Prostaglandins, 1976. Cited by 47 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Inhibition of prostaglandin biosynthesis by sulphasalazine and its metabolites. Papers, record 4854. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4854

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of prostaglandin biosynthesis by sulphasalazine and its metabolites.
PubMed
Journal
Prostaglandins
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
1.44
iCite
Revised in PubMed
2019-08-23
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Collier HOH O
2Francis AAA A
3McDonald-Gibson WJW J
4Saeed SAS A

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ProstaglandinsMajor topic
SulfasalazineMajor topic
Aminosalicylic Acids
Animals
Cattle
Depression, Chemical
Gastric Mucosa
Male
Rats
Seminal Vesicles
Sulfapyridine

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
37190315Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy.Cancers (Basel)2023https://conductscience.org/library/papers/37190315PubMed
34941734Tackling the Threat of Cancer Due to Pathobionts Producing Colibactin: Is Mesalamine the Magic Bullet?Toxins (Basel)2021https://conductscience.org/library/papers/34941734PubMed
28375885Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities.Inflamm Bowel Dis2017https://conductscience.org/library/papers/28375885PubMed
25685145Five-aminosalicylic Acid: an update for the reappraisal of an old drug.Gastroenterol Res Pract2015https://conductscience.org/library/papers/25685145PubMed
24005861Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer.Int J Mol Sci2013https://conductscience.org/library/papers/24005861PubMed
18716872Effects of N-acetylcysteine plus mesalamine on prostaglandin synthesis and nitric oxide generation in TNBS-induced colitis in rats.Dig Dis Sci2009https://conductscience.org/library/papers/18716872PubMed
18484800Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes.Drugs2008https://conductscience.org/library/papers/18484800PubMed
18475455Mechanism of action of 5-arninosalicylic acid.Mediators Inflamm1992https://conductscience.org/library/papers/18475455PubMed
7429322Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis.Gut1980https://conductscience.org/library/papers/7429322PubMed
7249885Do prostaglandins cause gastrointestinal mucosal injury?Dig Dis Sci1981https://conductscience.org/library/papers/7249885PubMed
6150882Prostaglandins and ulcerative colitis.Gut1984https://conductscience.org/library/papers/6150882PubMed
6149981Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.Gut1984https://conductscience.org/library/papers/6149981PubMed
6136395Prostanoids cytoprotection for maintaining remission in ulcerative colitis. Failure of 15(R), 15-methylprostaglandin E2.Dig Dis Sci1983https://conductscience.org/library/papers/6136395PubMed
6123357Ulcerative colitis: effect of sulphasalazine, its metabolites and indomethacin on the ability of human colonic mucosa to metabolize prostaglandins in vitro.Br J Pharmacol1982https://conductscience.org/library/papers/6123357PubMed
2877850Pharmacological and biochemical actions of sulphasalazine.Drugs1986https://conductscience.org/library/papers/2877850PubMed
1350243Sulfasalazine. Multiplicity of action.Dig Dis Sci1992https://conductscience.org/library/papers/1350243PubMed
40848Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone.Gut1979https://conductscience.org/library/papers/40848PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4854

GET https://conductscience.org/api/papers/v1/4854/authors